je.st
news
Tag: patient
Cerulean Announces First Patient Dosed In Phase 1/2 Trial Evaluating CRLX101 In Combination With LYNPARZA
2016-06-01 06:09:24| drugdiscoveryonline Home Page
Cerulean Pharma Inc., a clinical-stage company developing nanoparticle-drug conjugates (NDCs), recently announced that the first patient has been dosed in an open-label, single center Phase 1/2 clinical trial of its lead NDC candidate, CRLX101, in combination with LYNPARZA (olaparib) in patients with advanced solid tumors
Tags: with
trial
combination
phase
Merck Announces Results From Phase 3 Studies of ZEPATIER (Elbasvir and Grazoprevir) in Chronic Hepatitis C Patient Populations at The International Liver Congress
2016-04-16 07:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today announced the presentation of results from two Phase 3 clinical trials evaluating ZEPATIER (elbasvir and grazoprevir) 50mg/100mg tablets in chronic hepatitis C (HCV) patients with inherited blood disorders (C-EDGE IBLD) and in patients with a history of intravenous drug use who are receiving opioid agonist therapy (C-EDGE CO-STAR), respectively. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Sarra Herzog, 201-669-6570orInvestors:Teri Loxam, 908-740-1986Amy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: the
results
international
studies
Passavant Area Hospital Bolsters Already Stringent Cleaning Protocols for Added Patient Protection
2016-03-31 12:31:19| Industrial Newsroom - All News for Today
Tru-D SmartUVC Disinfection Robot to provide enhanced terminal room disinfection MEMPHIS, Tenn. - Passavant Area Hospital has added to its already strict cleaning strategies with the addition of Tru-D SmartUVC, a germ-eliminating UV disinfection robot. The hospital, located in Jacksonville, Illinois, is an...
Tags: area
added
protection
hospital
AutoNation Is a Buy for Patient Value Investors
2016-03-27 23:54:08| Auto Dealers - Topix.net
There are certainly plenty of pessimists about AutoNation Inc. , as shares have sold off the past year from $65 to about $48 today. Are the pessimists correct and is the drop justified? Or is this an opportunity for a realist to buy from those pessimists and benefit later when sentiment changes? For that matter, guru Mario Gabelli recently added AutoNation to his portfolio, and Edward Lampert and Bill Gates are among other gurus who own the stock.
Tags: buy
value
patient
investors
Medical DC/DC Converters offer 2 x MOPP, patient leakage to 2 A.
2016-03-24 13:31:06| Industrial Newsroom - All News for Today
JHL03 (3 W) and JHL06 (6 W) series are available with 5/12/15 Vdc single outputs and ±12 or ±15 Vdc dual outputs as well as 10–17 Vdc or 20–30 Vdc input. In addition to 5/12/15 Vdc single outputs, JHM15 (15 W) series offers ±5, ±12, or ±15 Vdc dual outputs and 2:1 input voltage range options of 9–18 Vdc or 18–36 Vdc. All models are encapsulated, isolated, and regulated DC/DC converters approved to 3rd edition international medical safety standards EN60601-1:2006 and ANSI/AAMI ES60601-1:2005.
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] next »